top of page
Image by Amy Hirschi
Business Meeting

Arstat Pharmaceuticals

Advancing 
Transformational Products for Tens of Millions of Women 

                   Seeking Partners for a                    Potentially Strong IPO

Our Portfolio

One of the Best Portfolios in Women’s Health
 

Eleven US Patents, two Phase III-ready products,
two potential blockbusters 

Happy Artist
Happy Woman Posing
Natural Beauty
Woman & Doctor
NUVOCEPT

TM

  The first and only 

contraceptive endorsed by the FDA for exclusive testing and labeling for overweight and obese women

 

(≈60% of 10 million US pill users)

  Addressing a high public health priority in the post-Roe world

PREMRING

TM

First-in-class 

medicated vaginal ring for uterine fibroids and endometriosis

 

(>15 million US women)

   Designed to drastically reduce the need for radical surgeries

ENHANTA

TM

First-in-class 

single non-hormonal therapy for painful, heavy menstrual periods

 

(>25 million US women)

Mission

Develop Safe and Effective Solutions for Highly Prevalent, Undertreated Reproductive Conditions and Disorders

​

Opportunity Details

​

Want to learn the Arstat basics?

Click the PDF below.

Overview

Presentation 

Ready to review this opportunity? Click the PDF below.

Contact Us

We are reaching out to partners,
executives, and advisors.  

bottom of page